Cargando…

Subversion of the Immune Response by Human Pathogenic Mycoplasmas

Mycoplasmas are a large group of prokaryotes which is believed to be originated from Gram-positive bacteria via degenerative evolution, and mainly capable of causing a wide range of human and animal infections. Although innate immunity and adaptive immunity play crucial roles in preventing mycoplasm...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Lianmei, Chen, Yiwen, You, Xiaoxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712165/
https://www.ncbi.nlm.nih.gov/pubmed/31497004
http://dx.doi.org/10.3389/fmicb.2019.01934
_version_ 1783446628165746688
author Qin, Lianmei
Chen, Yiwen
You, Xiaoxing
author_facet Qin, Lianmei
Chen, Yiwen
You, Xiaoxing
author_sort Qin, Lianmei
collection PubMed
description Mycoplasmas are a large group of prokaryotes which is believed to be originated from Gram-positive bacteria via degenerative evolution, and mainly capable of causing a wide range of human and animal infections. Although innate immunity and adaptive immunity play crucial roles in preventing mycoplasma infection, immune response that develops after infection fails to completely eliminate this bacterium under certain circumstances. Thus, it is reasonable to speculate that mycoplasmas employ some mechanisms to deal with coercion of host defense system. In this review, we will highlight and provide a comprehensive overview of immune evasion strategies that have emerged in mycoplasma infection, which can be divided into four aspects: (i) Molecular mimicry and antigenic variation on the surface of the bacteria to evade the immune surveillance; (ii) Overcoming the immune effector molecules assaults: Induction of detoxified enzymes to degradation of reactive oxygen species; Expression of nucleases to degrade the neutrophil extracellular traps to avoid killing by Neutrophil; Capture and cleavage of immunoglobulins to evade humoral immune response; (iii) Persistent survival: Invading into the host cell to escape the immune damage; Formation of a biofilm to establish a persistent infection; (iv) Modulation of the immune system to down-regulate the intensity of immune response. All of these features increase the probability of mycoplasma survival in the host and lead to a persistent, chronic infections. A profound understanding on the mycoplasma to subvert the immune system will help us to better understand why mycoplasma is so difficult to eradicate and ultimately provide new insights on the development of therapeutic regimens against this bacterium in future.
format Online
Article
Text
id pubmed-6712165
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-67121652019-09-06 Subversion of the Immune Response by Human Pathogenic Mycoplasmas Qin, Lianmei Chen, Yiwen You, Xiaoxing Front Microbiol Microbiology Mycoplasmas are a large group of prokaryotes which is believed to be originated from Gram-positive bacteria via degenerative evolution, and mainly capable of causing a wide range of human and animal infections. Although innate immunity and adaptive immunity play crucial roles in preventing mycoplasma infection, immune response that develops after infection fails to completely eliminate this bacterium under certain circumstances. Thus, it is reasonable to speculate that mycoplasmas employ some mechanisms to deal with coercion of host defense system. In this review, we will highlight and provide a comprehensive overview of immune evasion strategies that have emerged in mycoplasma infection, which can be divided into four aspects: (i) Molecular mimicry and antigenic variation on the surface of the bacteria to evade the immune surveillance; (ii) Overcoming the immune effector molecules assaults: Induction of detoxified enzymes to degradation of reactive oxygen species; Expression of nucleases to degrade the neutrophil extracellular traps to avoid killing by Neutrophil; Capture and cleavage of immunoglobulins to evade humoral immune response; (iii) Persistent survival: Invading into the host cell to escape the immune damage; Formation of a biofilm to establish a persistent infection; (iv) Modulation of the immune system to down-regulate the intensity of immune response. All of these features increase the probability of mycoplasma survival in the host and lead to a persistent, chronic infections. A profound understanding on the mycoplasma to subvert the immune system will help us to better understand why mycoplasma is so difficult to eradicate and ultimately provide new insights on the development of therapeutic regimens against this bacterium in future. Frontiers Media S.A. 2019-08-21 /pmc/articles/PMC6712165/ /pubmed/31497004 http://dx.doi.org/10.3389/fmicb.2019.01934 Text en Copyright © 2019 Qin, Chen and You. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Qin, Lianmei
Chen, Yiwen
You, Xiaoxing
Subversion of the Immune Response by Human Pathogenic Mycoplasmas
title Subversion of the Immune Response by Human Pathogenic Mycoplasmas
title_full Subversion of the Immune Response by Human Pathogenic Mycoplasmas
title_fullStr Subversion of the Immune Response by Human Pathogenic Mycoplasmas
title_full_unstemmed Subversion of the Immune Response by Human Pathogenic Mycoplasmas
title_short Subversion of the Immune Response by Human Pathogenic Mycoplasmas
title_sort subversion of the immune response by human pathogenic mycoplasmas
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712165/
https://www.ncbi.nlm.nih.gov/pubmed/31497004
http://dx.doi.org/10.3389/fmicb.2019.01934
work_keys_str_mv AT qinlianmei subversionoftheimmuneresponsebyhumanpathogenicmycoplasmas
AT chenyiwen subversionoftheimmuneresponsebyhumanpathogenicmycoplasmas
AT youxiaoxing subversionoftheimmuneresponsebyhumanpathogenicmycoplasmas